Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization

NCT04397718 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

FED

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Degarelix
OTHER: Saline

Sponsor

VA Office of Research and Development